new post
StocksRunner logo
mail
search
 
menu
 
Bristol-Myers Squibb
$59.98
-0.25%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

BMY Stock Analysis & IQ Rating | Bristol-Myers Squibb

 
 

BMY

 

Bristol-Myers Squibb

$59.98

 
-$0.15 | -0.25%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$62.89
 
 
MKT CAP
$122.15B
 
52W Low
$42.52
 
 
VOL
$8.67M
 
P/E Ratio
17.34
 
 
AVG VOL
$13.48M
 
RSI
50.74
 
 
TREND
Uptrend
 
 
 

BMY Stock IQ

 
lock  Login to see Bristol-Myers Squibb (BMY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

BMY Target Price

 
 
 

Strengths

 
 

BMY Rewards

 Upgraded on attractively valued

BMY Rewards

 Earnings are forecast to grow

BMY Rewards

 Trading below its fair value

BMY Rewards

 Investors confidence is positive

 
 

BMY Price Performance

 
 

$59.93   (+0.08%)

$52.41   (+14.44%)

$43.61   (+37.54%)

$59.21   (+1.30%)

 
 
1year
6month
3month
1month

BMY Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

BMY Earnings Sentiment Reported a strong earnings
BMY Earnings Sentiment Above analyst estimates
BMY Earnings Sentiment Earnings decline YoY

Rating

×

Rating

BMY Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

BMY Activity Sentiment Investors confidence is positive

Future

×

Future

BMY Future Sentiment Earnings are forecast to grow
BMY Future Sentiment Trading below its fair value
BMY Analysts Opinion

BMY Analysts opinion is negative but has improved from the past 3 months

BMY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%
Consensus Rating
100%
Buy
Opinion
NA
Trend
Score
100%
Potential
Score
BMY Street Sentiment

BMY Street Sentiment is extremely bullish and have negative views on the near-term outlook

BMY Risk Level

BMY has Low risk level

BMY Risk Level
Low
LOW
HIGH

BMY Performance Sentiment

Sentiments overview associated with events and the stock performance

100%
Positive
13 out of 13
events present
0%
Negative
0 out of 13
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$57.17
Resistance Price
$62.37
Current Price Range
$60.13
$57.17
$62.37
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
71%
Consensus Rating
BUY
5
Buy
2
Hold
0
Sell
Date
Action
Rating
Firm

Mar 10, 2026

 

Price Target Raised

 

Buy

 

UBS

 

Feb 09, 2026

 

Reiterate

 

Buy

 

Guggenheim

 

Jan 30, 2026

 

Price Target Raised

 

Neutral

 

Citi

 

Jan 22, 2026

 

Upgrade

 

a Buy

 

UBS

 

Jan 20, 2026

 

Upgrade

 

Buy

 

UBS

 
 
 
Runners Also Watch
Close Price
Change
 

JNJ

Johnson & Johnson

242.99

-0.30%

 
 
 
BMY Latest Analysis +
 
 
FAQ About BMY Stock Insights
 

What is BMY current stock price?

What are BMY stock strengths?

What is BMY Risk Level?

What is BMY market cap and volume?

What is BMY current Stock IQ?

Should I buy BMY stock right now?

Is BMY a Strong Buy right now?

What does a 'Strong Buy' rating mean for BMY?

What does a 'Strong Sell' rating mean for BMY?

What factors influence BMY's Stock IQ?

 
 
StocksRunner

Explore our BMY Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored BMY Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our BMY Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

BMY

 

Bristol-Myers Squibb

 
Set Alerts
 
 

Current Price

 

$59.98

 
-$0.15 | -0.25%
 
 
52W High
$62.89
 
 
MKT CAP
$122.15B
 
52W Low
$42.52
 
 
VOL
$8.67M
 
P/E Ratio
17.34
 
 
AVG VOL
$13.48M
 
RSI
50.74
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 

Runners Also Watch

 
 
 
Symbol
Close
Change
 

JNJ

Johnson & Johnson

242.99

-0.30%

 
 
 
 
 
user
 
 
 
 

BMY Price Performance

 
 

$59.93   (+0.08%)

$52.41   (+14.44%)

$43.61   (+37.54%)

$59.21   (+1.30%)

 
 
1year
6month
3month
1month
 

BMY Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

BMY Earnings Sentiment Reported a strong earnings
BMY Earnings Sentiment Above analyst estimates
BMY Earnings Sentiment Earnings decline YoY

Rating

×

Rating

BMY Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

BMY Activity Sentiment Investors confidence is positive

Future

×

Future

BMY Future Sentiment Earnings are forecast to grow
BMY Future Sentiment Trading below its fair value
BMY Analysts Opinion

BMY Analysts opinion is negative but has improved from the past 3 months

BMY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%
Consensus Rating
100%
Buy
Opinion
NA
Trend
Score
100%
Potential
Score
BMY Street Sentiment

BMY Street Sentiment is extremely bullish and have negative views on the near-term outlook

BMY Risk Level

BMY has Low risk level

BMY Risk Level
Low
LOW
HIGH
BMY Performance Sentiment
Sentiments overview associated with events and the stock performance.
100%
Positive
13 out of 13
events present
0%
Negative
0 out of 13
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$57.17
Resistance Price
$62.37
Current Price Range
$60.13
$57.17
$62.37
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

71%
Consensus Rating
BUY
5
Buy
2
Hold
0
Sell
Date
Action
Rating
Firm
Mar 10, 2026
Price Target Raised
Buy
UBS
Feb 09, 2026
Reiterate
Buy
Guggenheim
Jan 30, 2026
Price Target Raised
Neutral
Citi
Jan 22, 2026
Upgrade
a Buy
UBS
Jan 20, 2026
Upgrade
Buy
UBS
 
 
 
 

BMY Stock IQ

 
 
 
lock  Login to unlock Bristol-Myers Squibb (BMY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

BMY Rewards

 Upgraded on attractively valued

BMY Rewards

 Earnings are forecast to grow

BMY Rewards

 Trading below its fair value

BMY Rewards

 Investors confidence is positive

 
 
 

BMY Latest Analysis

 
 
 

UBS Boosts Bristol-Myers Squibb (BMY) Price Target as Milvexian Data Looms. Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 Stocks on the Verge of Becoming Dividend Aristocrats. On March 6 UBS raised its price recommendation on Bristol-Myers Squibb Company (NYSE:BMY) to $70 from $65 and maintained a Buy rating on the shares. The analyst said Phase III data for milvexian in stroke prevention and atrial [….]

 

Tue Mar 10, 2026

$60.13 | -0.80%
 
Rating

Bristol Myers Squibb Announces Positive Phase 3 Results For Mezigdomide In Multiple Myeloma . (RTTNews) - Bristol Myers Squibb (BMY) announced Monday positive interim Phase 3 results from the SUCCESSOR-2 study (NCT05552976).

 

Mon Mar 9, 2026

$60.63 | +0.56%
 
Activity

Bristol-Myers Squibb Company (BMY) Presents at TD Cowen 46th Annual Health Care Conference Transcript.

 

Mon Mar 2, 2026

$62.34 | -0.03%
 
Activity

FDA Accepts Bristol Myers Squibb (BMY) NDA for Iberdomide With Priority Review. Bristol-Myers Squibb Company (NYSE:BMY) is one of the best value stocks to buy now. On February 17 Bristol Myers Squibb announced that the FDA accepted its NDA for iberdomide which is an investigational treatment for patients with relapsed or refractory multiple myeloma/RRMM. If approved iberdomide would become the first in a new class of oral [….]

 

Tue Feb 24, 2026

$61.60 | +0.54%
 
Activity
 
 
 
 
 
StocksRunner

Discover BMY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of BMY. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our BMY Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BMY Stock trends

BMY Stock performance

BMY Stock analysis

BMY investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

BMY Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BMY

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BMY

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.